Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Bruna Raphaeli Silva"'
Autor:
Consuelo Diaz-Romero, Virgilio Souza e Silva, Iara K.F. Lustosa, Erika Ruiz-Garcia, Celso Abdon Lopes de Mello, Romina Luca, Juan Manuel O'Connor, Sinara Figueiredo Silva, Guillermo Mendez, Marcos Pedro Guedes Camandaroba, Bruna Raphaeli Silva Mattos, Rachel P. Riechelmann
Publikováno v:
Clinical Colorectal Cancer. 20:299-304
Background HIV-positive patients are underrepresented in clinical trials of metastatic squamous cell carcinoma of the anal canal (mSCCA). We aimed to compare the clinical outcomes of mSCCA patients according to HIV infection. Methods This was a retro
Autor:
Vladmir C. Cordeiro Lima, Marina de Paula Canal, Cynthia A Bueno, Marina Sonagli, Poliana de Andrade, Fernanda A Oliveira, Fabiana Baroni Alves Makdissi, Mariana P Xerfan, Sinara Figueiredo, Fernando Ab Campos, Solange Moraes Sanches, Monique Celeste Tavares, Rafaela Pirolli, Bruna Raphaeli Silva Mattos, Vinicius Fernando Calsavara, Marcelle Goldner Cesca, Camilla Albina Zanco Fogassa
Publikováno v:
Cancer Research. 80:P2-16
Introduction: Neoadjuvant chemotherapy in addition to increasing the rate of breast conservation, offers a invaluable opportunity to monitor individual tumor response which may be related to survival outcomes. In view of this, neoadjuvant treatment h
Autor:
Rafael Lima Viana, M.F. Simões, Fernando Augusto Batista Campos, Vladmir Cláudio Cordeiro de Lima, Luciana de Moura Leite, Bruna Raphaeli Silva Mattos, Paula Tavares Guimarães, Noam Pondé, Debora Maciel Santana, Daniella Dias Silva Sá, F. Rocha, Sinara Figueiredo Silva, Erick Figueiredo Saldanha, Solange Moraes Sanches, Marcelle Goldner Cesca, Rafaela Pirolli, Camilla Albina Zanco Fogassa, Monique Celeste Tavares, Simone Klog Loose
Purpose: Recently, phase I studies with novel antibody drug conjugates targeting HER2 suggested benefit in HER2-low patients – defined as immunohistochemistry(IHC) +1 or +2 FISH/ISH non-amplified, with advanced breast cancer(BC). Data on the progno
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d98fd26dd52572004e785fb728f0e6d0
https://doi.org/10.21203/rs.3.rs-420934/v1
https://doi.org/10.21203/rs.3.rs-420934/v1
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Poliana de Andrade, Marcelle Goldner Cesca, Monique Celeste Tavares, Solange Moraes Sanches, Flores Campos, V.C.C. de Lima, Camilla Albina Zanco Fogassa, Rafaela Pirolli, Simone Klog Loose, Luciana de Moura Leite, F.A. de Oliveira, Bruna Raphaeli Silva Mattos, Sinara Figueiredo Silva
Publikováno v:
Annals of Oncology. 31:S342
Autor:
Marcelle Goldner Cesca, Vladmir Cláudio Cordeiro de Lima, Solange Moraes Sanches, Fernanda A. Oliveira, Sinara Figueiredo Silva, Fernando Augusto Batista Campos, Rafaela Pirolli, Monique Celeste Tavares, Camilla Albina Zanco Fogassa, Poliana de Andrade, Mariana Pinheiro Xerfan, Luciana de Moura Leite, Bruna Raphaeli Silva Mattos
Publikováno v:
Web of Science
e12649 Background: Discordance between immunohistochemistry (IHC) and molecular subtyping from pre and post neoadjuvant chemotherapy (NACT) biopsy specimens in breast cancer (BC) patients (pts) varies in the literature. This information could have pr
Autor:
Veruska Lia Fook Alves, Djordje Atanackovic, Bruna Raphaeli Silva, Gisele W. B. Colleoni, Walter Moises Tobias Braga, Adriana Bruscato Bortoluzo
Publikováno v:
Immunotherapy. 6:569-575
Aim: The present study aimed at correlating the expression of cancer/testis antigens (CTAs) with the expression of genes related to tumor‐infiltrating T cells. Materials & methods: MAGE‐C1/CT‐7, MAGEA3/6, NY‐ESO‐1, LAGE‐1 and GAGE express
Autor:
Yumi H. Maekawa, Adriana Bruscato Bortoluzzo, Bruna Raphaeli Silva, Ana Carolina de Carvalho, Gisele W. B. Colleoni, Edgar Gil Rizzatti, Walter Moises Tobias Braga, Djordje Atanackovic
Publikováno v:
Cancer Immunology, Immunotherapy
Introduction Multiple myeloma (MM) development involves a series of genetic abnormalities and changes in the bone marrow (BM) microenvironment, favoring the growth of the tumor and failure of local immune control. T regulatory (Treg) cells play an im
Autor:
Bruna Raphaeli Silva, Walter Moises Tobias Braga, Fabricio de Carvalho, Gisele W. B. Colleoni, Veruska Lia Fook Alves
Publikováno v:
Blood. 120:4985-4985
Abstract 4985 Introdution: Cancer/Testis Antigens (CTAs) are a promising class of tumor antigens that have a limited expression in somatic tissues (testis, fetal ovary, and placental cells). CTAs are attractive targets for immunotherapy in cancer bec